Interestingly, the expression of these microRNAs temporally correlates with lymphedema onset and is hypothesized to increase lymphedema risk by interacting with transforming growth factor-β (TGF-β), PI3K-Akt, and MAPK signaling cascades [101]. The gene discussed is TGFB1; the disease is lymphedema.